Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May-Jun;119(3):266-270.

Cannabinoid Hyperemesis Syndrome: Lighting Up an Emergency Department Near You

Melanie Camcejo  1 , Emily Hillman  2 , Heather Isom  1
Affiliations

Cannabinoid Hyperemesis Syndrome: Lighting Up an Emergency Department Near You

Melanie Camcejo et al. Mo Med. 2022 May-Jun.

Abstract

Cannabis legalization may increase the rates of emergency department presentations and hospitalizations from Cannabinoid Hyperemesis Syndrome (CHS). This syndrome was first described nearly 20 years ago and has become increasingly common. Yet, for a variety of reasons, CHS is still an underrecognized cause of recurrent abdominal pain, nausea, and vomiting. All physicians must be prepared to diagnose, manage, and counsel patients on this condition, regardless of their state's current or future cannabis legislation.

PubMed Disclaimer

Conflict of interest statement

Disclosure None reported.

Figures

None
Pediatric, pregnant, diabetic ketoacidosis, and palliative care patients should be evaluated for CHS as well when presenting with intractable nausea and vomiting.
None
See this image and copyright information in PMC

References

    1. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383–1391. doi: 10.1016/s0140-6736(09)61037-0. - DOI - PubMed
    1. Allen JH, dede Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566–1570. doi: 10.1136/gut.2003.036350. - DOI - PMC - PubMed
    1. Zimmer DI, McCauley R, Konanki V, et al. Emergency department and radiological cost of delayed diagnosis of cannabinoid hyperemesis. J Addict. 2019;2019:1307345. doi: 10.1155/2019/1307345. - DOI - PMC - PubMed
    1. Cohen K, Weinstein AM. Synthetic and non-synthetic cannabinoid drugs and their adverse effects-a review from public health prospective. Frontiers Public Heal. 2018;6:162. doi: 10.3389/fpubh.2018.00162. - DOI - PMC - PubMed
    1. Perisetti A, Gajendran M, Dasari CS, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Ann Gastroenterol. 2020;33(6):1–8. doi: 10.20524/aog.2020.0528. - DOI - PMC - PubMed

LinkOut - more resources